Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway
| Autor: | M J Broekman, Jerold Brett, M C Oz, Hui Liao, Yoshifumi Naka, S Koga, Z. Taha, Aaron J. Marcus, Paul J. Cannon, David J. Pinsky |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
Male
Nitroprusside Transplantation Heterotopic medicine.medical_treatment Ischemia Biosensing Techniques Pharmacology Arginine Bradykinin Nitric Oxide Nitric oxide Rats Sprague-Dawley Nitroglycerin chemistry.chemical_compound medicine Animals Viaspan Cyclic GMP Heart transplantation biology Superoxide Dismutase business.industry Graft Survival Heart Organ Preservation General Medicine medicine.disease Coronary Vessels Rats Nitric oxide synthase Transplantation Endothelial stem cell Biochemistry chemistry Nitric Oxide Pathway biology.protein Heart Transplantation Amino Acid Oxidoreductases Nitric Oxide Synthase business Research Article Endocardium |
| Zdroj: | Journal of Clinical Investigation. 93:2291-2297 |
| ISSN: | 0021-9738 |
| Popis: | Nitric oxide (NO) is a novel biologic messenger with diverse effects but its role in organ transplantation remains poorly understood. Using a porphyrinic microsensor, the first direct measurements of coronary vascular and endocardial NO production were made. NO was measured directly in the effluent of preserved, heterotopically transplanted rat hearts stimulated with L-arginine and bradykinin; NO concentrations fell from 2.1 +/- 0.4 microM for freshly explanted hearts to 0.7 +/- 0.2 and 0.2 +/- 0.08 microM for hearts preserved for 19 and 38 h, respectively. NO levels were increased by SOD, suggesting a role for superoxide-mediated destruction of NO. Consistent with these data, addition of the NO donor nitroglycerin (NTG) to a balanced salt preservation solution enhanced graft survival in a time- and dose-dependent manner, with 92% of hearts supplemented with NTG surviving 12 h of preservation versus only 17% in its absence. NTG similarly enhanced preservation of hearts stored in University of Wisconsin solution, the clinical standard for preservation. Other stimulators of the NO pathway, including nitroprusside, L-arginine, or 8-bromoguanosine 3',5' monophosphate, also enhanced graft survival, whereas the competitive NO synthase antagonist NG-monomethyl-L-arginine was associated with poor preservation. Likely mechanisms whereby supplementation of the NO pathway enhanced preservation included increased blood flow to the reperfused graft and decreased graft leukostasis. NO was also measured in endothelial cells subjected to hypoxia/reoxygenation and detected based on its ability to inhibit thrombin-mediated platelet aggregation and serotonin release. NO became undetectable in endothelial cells exposed to hypoxia followed by reoxygenation and was restored to normoxic levels on addition of SOD. These studies suggest that the NO pathway fails during preservation/transplantation because of formation of oxygen free radicals during reperfusion, which quench available NO. Augmentation of NO/cGMP-dependent mechanisms enhances vascular function after ischemia and reperfusion and provides a new strategy for transplantation of vascular organs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|